Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added an important operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    4%
    Check dated 2025-10-05T10:22:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Version metadata updated from v3.0.2 to v3.1.0. No substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-13T17:46:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:28:33.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding new locations in Milan and Florence, Italy, while removing previous location references and related drug information.
    Difference
    4%
    Check dated 2025-08-30T12:14:41.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:49:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.